LFCR
Price
$6.51
Change
-$0.18 (-2.69%)
Updated
Oct 16, 04:59 PM (EDT)
Capitalization
244.66M
77 days until earnings call
Intraday Buy/Sell Signals
TLRY
Price
$1.54
Change
-$0.14 (-8.33%)
Updated
Oct 16, 04:59 PM (EDT)
Capitalization
1.73B
88 days until earnings call
Intraday Buy/Sell Signals
Interact to see
Advertisement

LFCR vs TLRY

Header iconLFCR vs TLRY Comparison
Open Charts LFCR vs TLRYBanner chart's image
Lifecore Biomedical
Price$6.51
Change-$0.18 (-2.69%)
Volume$2.02K
Capitalization244.66M
Tilray Brands
Price$1.54
Change-$0.14 (-8.33%)
Volume$456.97K
Capitalization1.73B
LFCR vs TLRY Comparison Chart in %
LFCR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TLRY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
LFCR vs. TLRY commentary
Oct 17, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LFCR is a Hold and TLRY is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 17, 2025
Stock price -- (LFCR: $6.68 vs. TLRY: $1.67)
Brand notoriety: LFCR: Not notable vs. TLRY: Notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: LFCR: 117% vs. TLRY: 130%
Market capitalization -- LFCR: $250.28M vs. TLRY: $1.73B
LFCR [@Pharmaceuticals: Generic] is valued at $250.28M. TLRY’s [@Pharmaceuticals: Generic] market capitalization is $1.73B. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $63.66B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.93B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

LFCR’s FA Score shows that 1 FA rating(s) are green whileTLRY’s FA Score has 0 green FA rating(s).

  • LFCR’s FA Score: 1 green, 4 red.
  • TLRY’s FA Score: 0 green, 5 red.
According to our system of comparison, both LFCR and TLRY are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

LFCR’s TA Score shows that 3 TA indicator(s) are bullish while TLRY’s TA Score has 4 bullish TA indicator(s).

  • LFCR’s TA Score: 3 bullish, 6 bearish.
  • TLRY’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, TLRY is a better buy in the short-term than LFCR.

Price Growth

LFCR (@Pharmaceuticals: Generic) experienced а -2.77% price change this week, while TLRY (@Pharmaceuticals: Generic) price change was -2.62% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was -0.52%. For the same industry, the average monthly price growth was +6.52%, and the average quarterly price growth was +55.08%.

Reported Earning Dates

LFCR is expected to report earnings on Jan 01, 2026.

TLRY is expected to report earnings on Jan 12, 2026.

Industries' Descriptions

@Pharmaceuticals: Generic (-0.52% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TLRY($1.73B) has a higher market cap than LFCR($245M). TLRY YTD gains are higher at: 15.789 vs. LFCR (-12.113). LFCR has higher annual earnings (EBITDA): -8.81M vs. TLRY (-2.11B). TLRY has more cash in the bank: 265M vs. LFCR (8.27M). LFCR has less debt than TLRY: LFCR (131M) vs TLRY (324M). TLRY has higher revenues than LFCR: TLRY (831M) vs LFCR (129M).
LFCRTLRYLFCR / TLRY
Capitalization245M1.73B14%
EBITDA-8.81M-2.11B0%
Gain YTD-12.11315.789-77%
P/E Ratio51.23N/A-
Revenue129M831M16%
Total Cash8.27M265M3%
Total Debt131M324M40%
FUNDAMENTALS RATINGS
LFCR vs TLRY: Fundamental Ratings
LFCR
TLRY
OUTLOOK RATING
1..100
6777
VALUATION
overvalued / fair valued / undervalued
1..100
98
Overvalued
52
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
10099
PRICE GROWTH RATING
1..100
6135
P/E GROWTH RATING
1..100
694
SEASONALITY SCORE
1..100
n/a85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TLRY's Valuation (52) in the Biotechnology industry is somewhat better than the same rating for LFCR (98) in the Industrial Specialties industry. This means that TLRY’s stock grew somewhat faster than LFCR’s over the last 12 months.

TLRY's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as LFCR (100) in the Industrial Specialties industry. This means that TLRY’s stock grew similarly to LFCR’s over the last 12 months.

TLRY's SMR Rating (99) in the Biotechnology industry is in the same range as LFCR (100) in the Industrial Specialties industry. This means that TLRY’s stock grew similarly to LFCR’s over the last 12 months.

TLRY's Price Growth Rating (35) in the Biotechnology industry is in the same range as LFCR (61) in the Industrial Specialties industry. This means that TLRY’s stock grew similarly to LFCR’s over the last 12 months.

LFCR's P/E Growth Rating (6) in the Industrial Specialties industry is significantly better than the same rating for TLRY (94) in the Biotechnology industry. This means that LFCR’s stock grew significantly faster than TLRY’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
LFCRTLRY
RSI
ODDS (%)
N/A
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
70%
Bullish Trend 2 days ago
90%
Momentum
ODDS (%)
Bearish Trend 2 days ago
79%
Bullish Trend 2 days ago
88%
MACD
ODDS (%)
Bearish Trend 2 days ago
72%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
77%
Bearish Trend 2 days ago
88%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
74%
Bullish Trend 2 days ago
82%
Advances
ODDS (%)
Bullish Trend 17 days ago
77%
Bullish Trend 8 days ago
83%
Declines
ODDS (%)
Bearish Trend 7 days ago
78%
Bearish Trend 3 days ago
89%
BollingerBands
ODDS (%)
Bullish Trend 7 days ago
85%
Bearish Trend 2 days ago
87%
Aroon
ODDS (%)
Bearish Trend 2 days ago
71%
Bullish Trend 2 days ago
83%
View a ticker or compare two or three
Interact to see
Advertisement
LFCR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TLRY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SOLCF0.040.01
+20.00%
SOL Global Investments Corp.
GFIOF46.623.72
+8.68%
Gold Fields Ltd.
ALGGY6.320.28
+4.64%
Alliance Global Group, Inc.
PBCO17.050.01
+0.06%
PBCO Financial Corporation
PILBF1.77-0.01
-0.56%
PILBARA MINERALS LTD

LFCR and

Correlation & Price change

A.I.dvisor indicates that over the last year, LFCR has been loosely correlated with NBIX. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if LFCR jumps, then NBIX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LFCR
1D Price
Change %
LFCR100%
-2.39%
NBIX - LFCR
36%
Loosely correlated
-0.15%
SHPH - LFCR
31%
Poorly correlated
-4.42%
AMRX - LFCR
30%
Poorly correlated
+0.92%
ALKS - LFCR
28%
Poorly correlated
-4.41%
PBH - LFCR
28%
Poorly correlated
+1.44%
More

TLRY and

Correlation & Price change

A.I.dvisor indicates that over the last year, TLRY has been closely correlated with SNDL. These tickers have moved in lockstep 76% of the time. This A.I.-generated data suggests there is a high statistical probability that if TLRY jumps, then SNDL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TLRY
1D Price
Change %
TLRY100%
-8.33%
SNDL - TLRY
76%
Closely correlated
-4.03%
CRON - TLRY
65%
Loosely correlated
-3.88%
OGI - TLRY
64%
Loosely correlated
-3.57%
CGC - TLRY
63%
Loosely correlated
-7.53%
ACB - TLRY
62%
Loosely correlated
-6.22%
More